Finding Text
Reference Number: 2024-002
Finding:
Finding Type: Immaterial noncompliance with major program requirements
Title and CFDA Number of Federal Program: 59.046 – Small Business Administration Microloan Program
Finding Resolution Status: Resolved
Information on Universe and Population Size: All quarterly and annual reports pursuant to the mutually agreed upon Reporting Schedule.
Sample Size Information: A sample of 3 reports for fiscal year 2024 were selected for testing compliance with reporting pursuant to the mutually agreed upon Reporting Schedule.
Identification of Repeat Finding and Finding Reference Number: N/A
Criteria: The Organization is required to submit the quarterly reports within 30 days following the reporting period.
Statement of Condition: The Organization failed to submit the SF PPR report as of December 31, 2023 by January 30, 2024. The report was filed March 22, 2024.
Cause: The Organization is unable to determine why the report was filed untimely. Personnel responsible for reporting at the time are no longer employed by the Organization.
Effect or Potential Effect: The Organization is noncompliant for the performance period ended December 31, 2023 with no sanctions imposed. The Organization submitted the requested report late.
Auditor Noncompliance Code: L - Reporting
Reporting Views of Responsible Officials: Management agrees with the noncompliance with no sanctions imposed conclusion.
Context: No additional context identified by the Organization which is not otherwise presented herein.
Recommendation: All requested reports should be submitted in accordance with the mutually agreed upon Reporting Schedule.
Auditor’s Summary of the Auditee’s Comments on the Findings and Recommendations: Management should submit all requested reports in accordance with the mutually agreed upon Reporting Schedule.
Response Indicator: Agree
Completion Date: March 1, 2025
Response: Management acknowledges noncompliance in the current fiscal year and has submitted the requested report to the awarding agency.
Questioned Costs: None